sodium chondroitin polysulfate (AMS Biotechnology)
96
Structured Review
AMS Biotechnology
sodium chondroitin polysulfate
Sodium Chondroitin Polysulfate, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csr-nacs-e2(sqc)3/Sodium+Chondroitin+Sulfate+E/pm27341458-43-17-20
Average 96 stars, based on 3 article reviews
Sodium Chondroitin Polysulfate, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csr-nacs-e2(sqc)3/Sodium+Chondroitin+Sulfate+E/pm27341458-43-17-20
Average 96 stars, based on 3 article reviews
sodium chondroitin polysulfate - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Labeling:Article Title: Effect of low-intensity pulsed ultrasound on the activity of osteoclasts: An in vitro study. Article Snippet: Objective: The objective of this in vitro study was to evaluate the effect of low-intensity pulsed ultrasound on the resorption activity of osteoclast cell cultures.. Design: RAW 264.7 cells were cultured and seeded over plates that were pre-coated with a synthetic carbonate apatite, and marked with fluoresceinamine-labeled sodium chondroitin polysulfate.. Plates were randomly divided into 4 groups according to the treatment assigned to each one of them: NO RANKL (no RANK-L addition and no ultrasound application), NO LIPUS (addition of RANK-L and no ultrasound application), LIPUS 10 (addition of RANK-L and 10 min of ultrasound application per day), and LIPUS 20 (addition of RANK-L and 20 min of ultrasound application per day). Affinity Magnetic Separation:Article Title: Effect of low-intensity pulsed ultrasound on the activity of osteoclasts: An in vitro study. Article Snippet: Objective: The objective of this in vitro study was to evaluate the effect of low-intensity pulsed ultrasound on the resorption activity of osteoclast cell cultures.. Design: RAW 264.7 cells were cultured and seeded over plates that were pre-coated with a synthetic carbonate apatite, and marked with fluoresceinamine-labeled sodium chondroitin polysulfate.. Plates were randomly divided into 4 groups according to the treatment assigned to each one of them: NO RANKL (no RANK-L addition and no ultrasound application), NO LIPUS (addition of RANK-L and no ultrasound application), LIPUS 10 (addition of RANK-L and 10 min of ultrasound application per day), and LIPUS 20 (addition of RANK-L and 20 min of ultrasound application per day). Incubation:Article Title: Effect of low-intensity pulsed ultrasound on the activity of osteoclasts: An in vitro study. Article Snippet: Objective: The objective of this in vitro study was to evaluate the effect of low-intensity pulsed ultrasound on the resorption activity of osteoclast cell cultures.. Design: RAW 264.7 cells were cultured and seeded over plates that were pre-coated with a synthetic carbonate apatite, and marked with fluoresceinamine-labeled sodium chondroitin polysulfate.. Plates were randomly divided into 4 groups according to the treatment assigned to each one of them: NO RANKL (no RANK-L addition and no ultrasound application), NO LIPUS (addition of RANK-L and no ultrasound application), LIPUS 10 (addition of RANK-L and 10 min of ultrasound application per day), and LIPUS 20 (addition of RANK-L and 20 min of ultrasound application per day). Saline:Article Title: Effect of low-intensity pulsed ultrasound on the activity of osteoclasts: An in vitro study. Article Snippet: Objective: The objective of this in vitro study was to evaluate the effect of low-intensity pulsed ultrasound on the resorption activity of osteoclast cell cultures.. Design: RAW 264.7 cells were cultured and seeded over plates that were pre-coated with a synthetic carbonate apatite, and marked with fluoresceinamine-labeled sodium chondroitin polysulfate.. Plates were randomly divided into 4 groups according to the treatment assigned to each one of them: NO RANKL (no RANK-L addition and no ultrasound application), NO LIPUS (addition of RANK-L and no ultrasound application), LIPUS 10 (addition of RANK-L and 10 min of ultrasound application per day), and LIPUS 20 (addition of RANK-L and 20 min of ultrasound application per day). |